Josée Côté

1.9k total citations
18 papers, 656 citations indexed

About

Josée Côté is a scholar working on Pharmacology, Surgery and Pharmacology. According to data from OpenAlex, Josée Côté has authored 18 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmacology, 6 papers in Surgery and 6 papers in Pharmacology. Recurrent topics in Josée Côté's work include Pharmacogenetics and Drug Metabolism (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Josée Côté is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Lipoproteins and Cardiovascular Health (5 papers) and Inflammatory mediators and NSAID effects (5 papers). Josée Côté collaborates with scholars based in United States, Belgium and Japan. Josée Côté's co-authors include John A. Wagner, Keith Gottesdiener, Arthur Bergman, Gary Herman, Rajesh Krishna, Suzanne K. Swan, Thomas Marbury, William B. Smith, Bingming Yi and Bo Jin and has published in prestigious journals such as The Lancet, Gastroenterology and Diabetes Care.

In The Last Decade

Josée Côté

17 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Josée Côté United States 12 371 311 162 132 115 18 656
Walter Krauwinkel Netherlands 23 355 1.0× 184 0.6× 168 1.0× 226 1.7× 201 1.7× 52 1.3k
Stephen Donahue United States 14 166 0.4× 583 1.9× 65 0.4× 64 0.5× 142 1.2× 31 1.1k
Jan Jaap van Lier United States 18 340 0.9× 149 0.5× 106 0.7× 123 0.9× 318 2.8× 38 1.0k
Mette Marie Hougaard Christensen Denmark 17 442 1.2× 266 0.9× 142 0.9× 289 2.2× 549 4.8× 34 1.1k
Sidney Rosenblatt United States 11 676 1.8× 383 1.2× 115 0.7× 61 0.5× 472 4.1× 13 1.3k
Thomas Littlejohn United States 22 601 1.6× 392 1.3× 222 1.4× 70 0.5× 222 1.9× 43 1.4k
Neil Hounslow United Kingdom 16 305 0.8× 604 1.9× 47 0.3× 43 0.3× 106 0.9× 35 858
Evelyne Chaput Switzerland 12 124 0.3× 211 0.7× 51 0.3× 138 1.0× 285 2.5× 15 597
A.N. Chremos United States 18 97 0.3× 333 1.1× 173 1.1× 64 0.5× 126 1.1× 26 821
Kazutaka Aoki Japan 19 677 1.8× 295 0.9× 92 0.6× 103 0.8× 300 2.6× 48 1.0k

Countries citing papers authored by Josée Côté

Since Specialization
Citations

This map shows the geographic impact of Josée Côté's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josée Côté with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josée Côté more than expected).

Fields of papers citing papers by Josée Côté

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josée Côté. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josée Côté. The network helps show where Josée Côté may publish in the future.

Co-authorship network of co-authors of Josée Côté

This figure shows the co-authorship network connecting the top 25 collaborators of Josée Côté. A scholar is included among the top collaborators of Josée Côté based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josée Côté. Josée Côté is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Krishna, Rajesh, Ferdous Gheyas, Josée Côté, et al.. (2018). Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy Subjects. The Journal of Clinical Pharmacology. 58(12). 1578–1585.
2.
Krishna, Rajesh, Ferdous Gheyas, Yang Liu, et al.. (2017). Pharmacokinetics and Pharmacodynamics of Anacetrapib Following Single Doses in Healthy, Young Japanese and White Male Subjects. The Journal of Clinical Pharmacology. 58(2). 254–262. 4 indexed citations
3.
Lauring, Brett, Xiujiang Li, Yang Liu, et al.. (2014). Influence of renal and hepatic impairment on the pharmacokinetics of anacetrapib. The Journal of Clinical Pharmacology. 54(11). 1247–1255. 8 indexed citations
4.
Anderson, Matt S., Josée Côté, Yang Liu, et al.. (2013). Effects of Rifampin, a Potent Inducer of Drug‐Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib. The Journal of Clinical Pharmacology. 53(7). 746–752. 14 indexed citations
5.
Krishna, Rajesh, Daria Stypinski, Amit Garg, et al.. (2012). Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. British Journal of Clinical Pharmacology. 74(1). 116–124. 8 indexed citations
6.
Côté, Josée. (2012). Les enjeux éthiques de l’utilisation d’internet en recherche : principales questions et pistes de solutions. Éthique Publique. vol. 14, n° 2. 4 indexed citations
7.
Lauring, Brett, Victor Dishy, Wen‐Lin Luo, et al.. (2009). Laropiprant in Combination With Extended‐Release Niacin Does Not Alter Urine 11‐Dehydrothromboxane B2, a Marker of In Vivo Platelet Function, in Healthy, Hypercholesterolemic, and Diabetic Subjects. The Journal of Clinical Pharmacology. 49(12). 1426–1435. 12 indexed citations
8.
Bergman, Arthur, Josée Côté, Andrea Maes, et al.. (2009). Effect of Sitagliptin on the Pharmacokinetics of Simvastatin. The Journal of Clinical Pharmacology. 49(4). 483–488. 29 indexed citations
9.
10.
Laere, Koen Van, Michel Koole, Sandra Sanabria Bohórquez, et al.. (2008). Whole-Body Biodistribution and Radiation Dosimetry of the Human Cannabinoid Type-1 Receptor Ligand 18F-MK-9470 in Healthy Subjects. Journal of Nuclear Medicine. 49(3). 439–445. 24 indexed citations
11.
Krishna, Rajesh, Arthur Bergman, Bo Jin, et al.. (2008). Assessment of the CYP3A‐Mediated Drug Interaction Potential of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Volunteers. The Journal of Clinical Pharmacology. 49(1). 80–87. 31 indexed citations
12.
Krishna, Rajesh, Arthur Bergman, Patrick Larson, et al.. (2007). Effect of a Single Cyclosporine Dose on the Single‐Dose Pharmacokinetics of Sitagliptin (MK‐0431), a Dipeptidyl Peptidase‐4 Inhibitor, in Healthy Male Subjects. The Journal of Clinical Pharmacology. 47(2). 165–174. 56 indexed citations
13.
14.
Schwartz, Jules I., Nancy Agrawal, Alan Hartford, et al.. (2007). The Effect of Etoricoxib on the Pharmacodynamics and Pharmacokinetics of Warfarin. The Journal of Clinical Pharmacology. 47(5). 620–627. 12 indexed citations
15.
Bergman, Arthur, Josée Côté, Bingming Yi, et al.. (2007). Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor. Diabetes Care. 30(7). 1862–1864. 151 indexed citations
16.
Agrawal, Nancy, Catherine Z. Matthews, Ralph S. Mazenko, et al.. (2003). Pharmacokinetics of Etoricoxib in Patients with Renal Impairment. The Journal of Clinical Pharmacology. 44(1). 48–58. 32 indexed citations
17.
Agrawal, Nancy, Mark J. Rose, Catherine Z. Matthews, et al.. (2003). Pharmacokinetics of Etoricoxib in Patients with Hepatic Impairment. The Journal of Clinical Pharmacology. 43(10). 1136–1148. 19 indexed citations
18.
Calder, Nicole, Aimée Dallob, Peggy Wong, et al.. (2000). Evidence that the COX-2 specific inhibitor rofecoxib at 50 mg spares gastric mucosal prostaglandin synthesis in human. Gastroenterology. 118(4). A253–A253. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walter Krauwinkel Breakdown of academic impact, for papers by Stephen Donahue Breakdown of academic impact, for papers by Jan Jaap van Lier Breakdown of academic impact, for papers by Mette Marie Hougaard Christensen Breakdown of academic impact, for papers by Sidney Rosenblatt Breakdown of academic impact, for papers by Thomas Littlejohn Breakdown of academic impact, for papers by Neil Hounslow Breakdown of academic impact, for papers by Evelyne Chaput Breakdown of academic impact, for papers by A.N. Chremos Breakdown of academic impact, for papers by Kazutaka Aoki
Rankless by CCL
2026